Regulations.gov document
Determination That CYTOXAN (Cyclophosphamide) for Injection (Sterile Dry Powder…
Notice · FDA-2023-P-2655 · posted Oct 12, 2023
Key facts
| Document ID | FDA-2023-P-2655-0009 |
|---|---|
| Title | Determination That CYTOXAN (Cyclophosphamide) for Injection (Sterile Dry Powder Excipient-Free Formulation), 500 Milligrams/Vial, 1 Gram/Vial, and 2 Grams/Vial, and CYTOXAN (Cyclophosphamide) for Injection (Sterile Dry Powder With Sodium Chloride Formulation), 500 Milligrams/Vial, 1 Gram/Vial, and 2 Grams/Vial, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness |
| Document type | Notice |
| Subtype | Determinations |
| Agency | FDA |
| Docket | FDA-2023-P-2655 |
| Posted | Oct 12, 2023 |
| Federal Register citation | 88 FR 70665 |
| FR document number | 2023-22494 |
| Comment period opens | Oct 12, 2023 |
| Effective date | Oct 12, 2023 |
At a glance
- 1–9 Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: